OUR CLIENTS

Generis now has over
270,000 licensed users
of its software

0
licensed users and counting

Life Sciences

  • 3M Healthcare
  • Abbott Pharmaceuticals
  • Aegerion Pharmaceuticals
  • Agios Pharmaceuticals
  • AstraZeneca
  • Bayer HealthCare
  • Bayer Crop Science
  • Biogen
  • Blue Cross Blue Shield
  • Bristol-Myers Squibb
  • Cambridge Biomedical
  • Fresenius Kabi
  • Gilead Sciences
  • Hawaii Medical Services
  • Ipsen Pharmaceuticals
  • Johnson & Johnson
  • Kadmon Pharmaceuticals
  • MedImmune
  • Merck KGaA
  • Mylan Pharmaceuticals
  • Novartis Pharma
  • Novartis Animal Health
  • Otsuka Pharmaceutical
  • Pfizer
  • Pierre Fabre
  • Roche
  • Talecris Biotherapeutics (Grifols)
  • UCB
  • ViroPharma
  • WebMD

Engineering

  • BHP Billiton
  • Pratt & Whitney

Government

  • City of Sacramento
  • Miami-Dade County
  • State of North Carolina
  • New South Wales Railcorp
  • US Department of Homeland Security

Oil & Gas / Chemical

  • Chevron
  • Covestro
  • Dow Corning
  • MEG Energy
  • Suncor
  • Total Oil

Insurance & Financial

  • ATB Financial
  • Fannie Mae
  • Gen Re
  • Hannover Life Re
  • MFS
  • Scottish Re

Media

  • QVC Television
  • Walt Disney Studios

Other

  • Navitas
  • Sargento Foods
  • The Taubman Company

CARA and the competition

“We did a comparison of D2 vs. CARA to replace Webtop and found CARA to be far superior in the features our users, as well as our IT department and Documentum Administrators, value. We then did an extensive POC with Generis to prove out our initial observations. In addition to a very robust, stable, and highly configurable product, there were two other things that tipped the scales dramatically in favor of CARA. One was the responsiveness of Generis to suggestions for enhancements and the remarkable turn-around time in which we were given the updates for testing purposes. The other was just how pleasurable it was to work with a company like Generis where we felt valued as a customer. When we demoed CARA to our user focus groups, an overwhelming majority of participants recommended we move ahead with the purchase and stated they looked forward to working with this new tool.”

BARB BUSCHMANN | IT DIRECTOR, SARGENTO

World’s 2nd largest Life Sciences co

This company recently evaluated CARA against D2 and selected CARA to replace Webtop through multiple business units with over 20,000 users.

General Reinsurance

Gen Re selected CARA after piloting both CARA and D2, again to replace Documentum Webtop. The deployment has recently been confirmed to be enterprise-wide.